Endothelial progenitor cells’ ‘homing’ specificity to brain tumors.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 811, doi. 10.1038/sj.gt.3302151
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2004 AND VI 11 AND IP 10
Results: 9
1
2
Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 829, doi. 10.1038/sj.gt.3302226
- By:
- Publication type:
- Article
3
Sea urchin insulator protects lentiviral vector from silencing by maintaining active chromatin structure.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 819, doi. 10.1038/sj.gt.3302227
- By:
- Publication type:
- Article
4
Targeted conversion of the transthyretin gene in vitro and in vivo.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 838, doi. 10.1038/sj.gt.3302228
- By:
- Publication type:
- Article
5
Liposomal gene transfer of multiple genes is more effective than gene transfer of a single gene.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 847, doi. 10.1038/sj.gt.3302229
- By:
- Publication type:
- Article
6
Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 865, doi. 10.1038/sj.gt.3302230
- By:
- Publication type:
- Article
7
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 856, doi. 10.1038/sj.gt.3302231
- By:
- Publication type:
- Article
8
Gene Therapy Progress and Prospects: Recombinant adeno-associated virus (rAAV) vectors.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 805, doi. 10.1038/sj.gt.3302233
- By:
- Publication type:
- Article
9
Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
- Published in:
- Gene Therapy, 2004, v. 11, n. 10, p. 874, doi. 10.1038/sj.gt.3302249
- By:
- Publication type:
- Article